Analystreport

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target raised by analysts at Royal Bank of Canada from $23.00 to $34.00. They now have an "outperform" rat

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com